There has been a revolution in nanotechnology and nanomedicine. Since 1980, there has
been a remarkable increase in approved nano-based pharmaceutical products. These novel …

Acute kidney injury (AKI) is a common and serious problem affecting millions and causing
death and disability for many. In 2012, Kidney Disease: Improving Global Outcomes …

In 2000, the National Institute of Health launched the National Nanotechnology Initiative to
support, coordinate, and advance research and development of nanoscale projects. The …

Among several promising new drug-delivery systems, liposomes represent an advanced
technology to deliver active molecules to the site of action, and at present several …

Applications of nanotechnology for treatment, diagnosis, monitoring, and control of
biological systems has recently been referred to as “nanomedicine” by the National Institutes …

Phytochemicals, such as terpenes, polyphenols, and tannins, have been used in history, for
the treatment of illnesses and fever. Phytochemicals are easily available in nature, can be …

“Amphotericin B acts through pore formation at the cell membrane after binding to
ergosterol” is an accepted dogma about the action mechanism of this antifungal, and this …

The combination of liposomes with polymeric scaffolds could revolutionize the current state
of drug delivery technology. Although liposomes have been extensively studied as a …

Toxicity of nanocarrier systems involves physiological, physicochemical, and molecular
considerations. Nanoparticle exposures through the skin, the respiratory tract, the …

Amphotericin B (AMB) is an antifungal drug that binds to ergosterol and forms pores at the
cell membrane, causing the loss of ions. In addition, AMB induces the accumulation of …